Contact
Please use this form to send email to PR contact of this press release:
Modulo Bio Joins Lilly Gateway Labs to Accelerate Development of Neuroimmune Therapies for ALS, FTD and Alzheimer's
TO:
Michael Horowitz
Modulo Bio, Inc.
+1 650-383-0112